logo
AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

Business Wire2 days ago

BUSINESS WIRE)-- AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of 'a' (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of 'aa-' (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companies and ratings.)
The ratings reflect UnitedHealthcare's balance sheet strength, which AM Best assesses as strong, as well as its very strong operating performance, very favorable business profile and appropriate enterprise risk management (ERM).
The revision of the outlooks to negative from stable reflects the expected deterioration in operating performance in 2025 driven by the Medicare Advantage segment. In UnitedHealth Group's first-quarter earnings, the company noted an acceleration in trends in the Medicare Advantage segment that occurred late in the quarter. In May 2025, the company announced that trends continued to accelerate and broadened to more types of benefit offerings. Additionally, UnitedHealth Group noted that the medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare remained higher than expected. Due to the design of the Medicare Advantage program, UnitedHealthcare is unable to implement corrective pricing actions until 2026, and the issues within the Medicare Advantage segment are expected to persist for the remainder of 2025. AM Best will continue to monitor UnitedHealth Group's operating performance and may take rating action should operating performances no longer be in line with the very strong assessment.
UnitedHealthcare's risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio, is at the very strong level. Capital and surplus growth is supported by retained net earnings in excess of dividends to the parent. UnitedHealthcare actively manages subsidiary risk-adjusted capital on a near- to long-term basis to ensure capital levels are supportive of premium growth. Investment risk is on the low side with a conservative asset allocation and no material exposure to equities, real estate or schedule BA assets.
UnitedHealthcare holds a substantial market share in all lines of business and on a national basis. Premiums and earnings are well-diversified by business segment and geography. Furthermore, its large membership base provides economies of scale.
UnitedHealth Group's ERM program is developed, and the group's risk management capabilities are aligned with its risk profile. The ERM program is dynamic and utilized in daily operations and strategic business planning. However, AM Best recognizes the missteps that have occurred within the organization, including the Change Healthcare cyber-attack as well as the issues addressed in the recent earnings announcements. AM Best evaluates UnitedHealth Group's ERM as appropriate.
UnitedHealth Group has strong financial flexibility with material non-regulated operating cash flows from its Optum operations. Equity has shown consistent growth over the past five years, driven entirely by retained earnings despite large share repurchases and growing dividend programs. Strong liquidity is driven by favorable operating cash flows, parent company cash, a commercial paper program and a $21 billion revolving credit facility. Financial leverage at year-end 2024 was elevated at 43.7%, as measured by AM Best, and is above the company's long-term target of 40%. Additionally, earnings before interest and tax coverage remained good but declined in 2024 to about eight times. Furthermore, UnitedHealth Group had a large amount of goodwill and intangibles on the balance sheet totaling approximately 132% of equity. There has been no history of any material impairments and acquired assets continue to contribute favorably to revenues and earnings.
A complete listing of UnitedHealth Group's FSRs and Long-Term ICRs, as well as Short- and Long-Term IRs, is available.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

PVH (PVH) Gets a Buy from TD Cowen
PVH (PVH) Gets a Buy from TD Cowen

Business Insider

timean hour ago

  • Business Insider

PVH (PVH) Gets a Buy from TD Cowen

TD Cowen analyst John Kernan reiterated a Buy rating on PVH (PVH – Research Report) yesterday and set a price target of $98.00. The company's shares closed yesterday at $66.30. Confident Investing Starts Here: Kernan covers the Consumer Cyclical sector, focusing on stocks such as Dick's Sporting Goods, Ralph Lauren, and Burlington Stores. According to TipRanks, Kernan has an average return of 10.5% and a 55.75% success rate on recommended stocks. In addition to TD Cowen, PVH also received a Buy from Needham's Tom Nikic in a report issued yesterday. However, on the same day, Wells Fargo maintained a Hold rating on PVH (NYSE: PVH).

Luigi Mangione's Chilling Diary Reveals Motive on CEO Killing
Luigi Mangione's Chilling Diary Reveals Motive on CEO Killing

Yahoo

timean hour ago

  • Yahoo

Luigi Mangione's Chilling Diary Reveals Motive on CEO Killing

A red notebook could hold the motive behind one of the most jarring killings in corporate America. ABC News reported that according to a new court filing, diary entries written by 27-year-old Luigi Mangione reveal his thinking before he allegedly gunned down UnitedHealthcare CEO Brian Thompson in Manhattan last December. Mangione, who has pleaded not guilty to all charges, was arrested hours later at a McDonald's in Pennsylvania. The handwritten entries detail Mangione's rage against the health insurance industry and his belief that a high-profile killing could ignite a broader conversation. 'The target is insurance,' he wrote in August 2024. 'It checks every box.' The Manhattan District Attorney's Office filed the notebook excerpts in response to Mangione's legal team, which sought to pause or dismiss the case. Prosecutors argue that the writings—alongside the fact that shell casings at the scene were etched with the words 'delay,' 'deny' and 'depose'—show clear intent to commit murder in furtherance of terrorism. Mangione, a former Ivy League student from a privileged background, allegedly viewed the killing as a way to strike at what he saw as systemic greed. 'Do you bomb the HQ? No. Bombs=terrorism,' he wrote. 'Targeted, precise and doesn't risk innocents.' Prosecutors say the killing triggered a cascade of threats against health insurance employees, forcing UnitedHealthcare to pull executive headshots from its website, hire private security, and advise employees to stop wearing branded clothing. Despite the violence, Mangione has become a cult-like figure to some online. A legal defense fund has raised more than $1 million, and many frustrated with rising health costs have voiced support. The motive, authorities argue, wasn't personal. It was symbolic. 'He chose UHC solely because they were the largest,' the filing reads. The entry explains Mangione's motive in this high-profile, shocking case. Luigi Mangione's Chilling Diary Reveals Motive on CEO Killing first appeared on Men's Journal on Jun 6, 2025

Fiserv to Acquire AIB Merchant Services
Fiserv to Acquire AIB Merchant Services

Business Wire

time2 hours ago

  • Business Wire

Fiserv to Acquire AIB Merchant Services

MILWAUKEE & DUBLIN--(BUSINESS WIRE)-- Fiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services technology, announced today that it has agreed to acquire the remaining 49.9% of AIB Merchant Services (AIBMS), its joint venture with AIB Group, in a transaction focused on driving continued growth in Ireland and the broader European market. Founded in 2007, AIBMS is one of Ireland's largest payment solution providers and one of Europe's largest e-commerce acquirers. AIBMS has been very successful to date and AIB Group will continue to work exclusively with AIBMS and Fiserv by referring customers who require merchant acquiring services. Financial terms of the transaction were not disclosed. 'We have enjoyed a strong partnership with AIB Group, as together we grew AIBMS into one of the leading acquirers in Europe, and I look forward to continuing to work closely with them to support our mutual clients,' said Katia Karpova, Head of the EMEA region at Fiserv. 'Our focus will remain on delivering market-leading solutions to clients of all sizes across Ireland and the broader European market. We are particularly excited for the opportunity to accelerate the local penetration and growth of Clover, the world's smartest point-of-sale system and business management platform.' 'Following a successful Joint Venture partnership, we believe Fiserv has the commitment, experience and innovative technical solutions to grow AIBMS and that our customers will continue to be well-served under their sole ownership,' said Colin Hunt, Chief Executive Officer of AIB. 'Recognising the strength of the AIB customer franchise, we are pleased to support our business customers by maintaining a close on-going relationship with Fiserv. AIB continues to implement its strategy at pace, with strong progress in each of our three focus areas: Customer First, Greening our Business and Operational Efficiency and Resilience. We wish AIBMS and Fiserv every success in the future.' The transaction is subject to regulatory approvals and closing conditions and is expected to close in the third quarter. About Fiserv Fiserv, Inc. (NYSE: FI), a Fortune 500 company, moves more than money. As a global leader in payments and financial technology, the company helps clients achieve best-in-class results through a commitment to innovation and excellence in areas including account processing and digital banking solutions; card issuer processing and network services; payments; e-commerce; merchant acquiring and processing; and Clover®, the world's smartest point-of-sale system and business management platform. Fiserv is a member of the S&P 500® Index and one of Fortune® World's Most Admired Companies™. Visit and follow on social media for more information and the latest company news. About AIB AIB is a financial services group operating predominantly in Ireland and the United Kingdom. We provide a range of services to retail, business and corporate customers, with market-leading positions in key segments. AIB is the principal brand across all geographies. In Ireland, EBS is our challenger brand and Haven is our mortgage broker channel. For further information, please visit FI-G

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store